A trial looking at targeted drugs for mesothelioma (MiST)

This trial looked at several different treatments for mesothelioma that had continued to grow or had come back after chemotherapy.

MiST stands for Mesothelioma Stratified Therapy. The trial was designed to look at several new and different treatments at the same time. Some treatments were for anyone with advanced mesothelioma. Some were for people with specific gene or protein changes. There is more detail about this below.

The trial was open for people to join between 2019 and 2022. The team have published and presented results for the different groups between 2021 and 2024.